Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01334801 · ClinicalTrials.gov registry record

Biomarkers in Aortic Stenosis - B.A.S.S.

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
378
Enrollment target

NCT01334801: Completed study, sponsored by Mayo Clinic.

NCT01334801 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 378 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01334801 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
378 participants
Enrollment target

Study Summary

This study is being done to determine whether or not new blood test(s) can determine the severity of heart conditions. Aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associated with pacemaker leads are the cardiac disorders under study. The blood tests involve analysis for von Willebrand Factor antigen and activity, von Willebrand Factor multimers, and brain natriuretic peptide (BNP) levels. The results of the blood tests will be compared to the information from the clinically-indicated echocardiogram and one blood test compared to another.

Interventions

  • PROCEDURE Blood Draw

Trial Details

FieldValue
Enrollment Target 378 participants
Start Date 2010-07
Est. Completion 2020-01-31

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01334801

The ClinicalTrials.gov registry entry for NCT01334801 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 378 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.

NCT01334801 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01334801 about?

NCT01334801 is a clinical study titled "Biomarkers in Aortic Stenosis - B.A.S.S.". This study is being done to determine whether or not new blood test(s) can determine the severity of heart conditions. Aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associa...

What is the current status of trial NCT01334801?

This trial is currently completed. The enrollment target is 378 participants. The study started on 2010-07. Estimated completion is 2020-01-31.

What interventions are being tested in trial NCT01334801?

The interventions under investigation include: Blood Draw (PROCEDURE).

Who is sponsoring clinical trial NCT01334801?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.